Averion International Corp. is a full service clinical research organization (CRO) that provides clinical research and staffing services to the pharmaceutical, biotechnology and medical device/diagnostic industries. The Company has a therapeutic focus in oncology, medical devices, dermatology, and nephrology.
Averion's clinical research core competencies are in FDA and product registration support, site selection, project management, medical and site monitoring, data management, biometrics, pharmacovigilance, medical writing, and full clinical trial management services throughout the clinical trials lifecycle.
The Company has supported FDA approvals for products in many therapeutic areas including:
The Company also provides staffing services to help solve many regulatory andvalidation problems faced by clients throughout the product development lifecycle.
15-Oct-2007 - Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late involving Clinsys, Averion, PRA International and others.
11-Sep-2007 - Averion has formed a new partnership in South America's clinical trial hotspot Brazil - as it continues to tip-toe beyond North America and Europe into emerging markets.
30-May-2007 - When using contractors, many companies are wasting precious time getting projects off the ground due to poor early-stage planning, according to Kevin Martin, vice president of Averion LifeSciences Staffing Support.
07-Feb-2007 - US-based Averion has signed a deal with an Indian contract research organisation (CRO) to offer combined services to pharma and biotech companies.
24-Aug-2006 - Two US contract research organisations (CROs), Averion and IT&E International, have joined to forces to specialise in the area of oncology services.
16-Feb-2006 - Contract Research Organisation (CRO) Averion, and the SIPLAS Research Organisation has signed an agreement to provide promotion and support of clinical trials in a move that that reinforces Latin America as an emerging hub of clinical trial service providers.